Topiramate vs Ozempic for Weight Loss: What the Evidence Shows

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss medications fall into different drug classes, each working through unique biological pathways. Topiramate, an anticonvulsant used off-label for weight management, produces modest weight loss by reducing appetite and increasing satiety. Semaglutide, a GLP-1 receptor agonist, delivers substantially stronger results by mimicking a hormone that regulates hunger and blood sugar, with clinical trials showing average weight loss of 15–22% of body weight over 68 weeks.

How Topiramate Works for Weight Management

Topiramate is an anticonvulsant originally developed to treat seizures and migraine prevention. When prescribed off-label for weight loss, it functions by altering brain chemistry to suppress appetite and enhance feelings of fullness after eating. The medication may also increase metabolic rate modestly and reduce cravings for certain foods.

Clinical studies on topiramate for weight loss typically show reductions of 5–10% of baseline body weight over 24 weeks when combined with lifestyle changes. Some patients report decreased hunger within 1–2 weeks of starting the medication. However, weight loss plateaus occur frequently, and discontinuing the medication often results in rapid weight regain.

Semaglutide's GLP-1 Mechanism and Clinical Results

Semaglutide activates GLP-1 receptors throughout the body, triggering multiple weight loss pathways simultaneously. It slows gastric emptying so food stays in your stomach longer, amplifies the brain's satiety signals, reduces insulin resistance, and decreases cravings for high-calorie foods. This multi-system approach produces more consistent and durable weight loss than single-pathway medications.

The STEP trials, which followed over 4,500 patients receiving semaglutide injections weekly, demonstrated average weight loss of 15–22% of body weight at the highest doses. Approximately 80% of participants achieved clinically meaningful weight loss (≥5% of baseline weight). Crucially, semaglutide's benefits persist as long as the medication is taken, with weight stabilization rather than rapid rebound after discontinuation in many patients.

Side Effect Profiles: Tolerability Differences

Topiramate's common side effects include cognitive dulling, paresthesias (tingling sensations), increased heart rate, and mood changes in some users. Approximately 10–15% of patients discontinue topiramate due to intolerable neurological effects. The medication also carries a black box warning for birth defects if used during pregnancy, restricting its use in women of reproductive age.

Semaglutide's primary side effects are gastrointestinal—nausea, vomiting, diarrhea, and constipation—that typically emerge when doses increase and diminish over 4–8 weeks as the body adjusts. Serious pancreatitis is rare but requires immediate medical attention. Most patients tolerate semaglutide well when dosing is gradual and they receive proper counseling on eating smaller portions and staying hydrated. Unlike topiramate, GLP-1 therapy poses no cognitive risk and is not contraindicated in pregnancy.

Cost, Access, and Personalization at PlexusDx

PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies at a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement and full HSA/FSA eligibility. Because your dose may increase over your treatment course, PlexusDx applies the pricing rule: your dose may go up, your price won't. This means maximum predictability for your weight loss investment across all three commitment tiers.

For patients seeking deeper insight into their body's peptide response, PlexusDx offers the Precision Peptide Genetic Test ($298). This test analyzes 14 metabolic and appetite-regulation pathways—including GIPR rs1800437, and FTO rs9939609 variants—to reveal genetic predispositions that influence how your body responds to GLP-1 therapy versus other weight loss approaches. This personalization ensures you're matched to the medication and dose most likely to work for your genetic makeup.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Which medication produces faster weight loss: topiramate or semaglutide?

Semaglutide typically delivers faster and more substantial weight loss. Patients on semaglutide often see 5–10% weight loss within 12–16 weeks, whereas topiramate usually takes 8–12 weeks to produce 5–10% weight loss. Semaglutide's average final weight loss (15–22%) far exceeds topiramate's typical plateau (5–10%).

Can topiramate and semaglutide be used together?

While some physicians prescribe combination therapy, semaglutide's superior efficacy and side effect profile make dual therapy rarely necessary. Combining medications increases costs and potential adverse effects without robust evidence of superior outcomes. A personalized approach through genetic testing can help identify whether you're a candidate for monotherapy with semaglutide alone.

Is compounded semaglutide as effective as brand-name Ozempic?

PlexusDx sources compounded semaglutide from licensed 503A pharmacies using the same active pharmaceutical ingredient as brand medications. The clinical effectiveness is equivalent; the primary difference is cost—PlexusDx's flat-rate pricing ($189/mo starting) is dramatically lower than brand-name alternatives, making evidence-based GLP-1 therapy accessible.

What if I have a family history of pancreatitis—is semaglutide safe?

Semaglutide carries a warning about pancreatitis risk, though serious cases remain rare (less than 0.1% of patients in major trials). If you have personal or close family history of acute or chronic pancreatitis, you should discuss this with your PlexusDx provider before starting therapy. They may recommend baseline pancreatic assessment or close monitoring.

How does the PlexusDx Precision Peptide Genetic Test help choose between these medications?

The test analyzes variants in GIPR and FTO, and MC4R genes that directly influence hunger signaling and metabolic rate. If your genetic profile shows strong GLP1R activation potential, semaglutide is statistically more likely to deliver robust weight loss. If other variants suggest weaker GLP-1 pathway response, PlexusDx can discuss alternative combinations or dosing strategies tailored to your genetics.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.